Pacemaker

Abbott announced that the FDA approved the world’s first dual-chamber leadless pacing system, which will open up leadless pacemaker technology to a broader population.

A leadless, ultrasound-based endocardial pacing system was able to deliver cardiac resynchronization therapy to patients unable to be implanted with conventional CRT devices, researchers reported.

A dual-chamber leadless pacemaker was successfully implanted in most patients and met its 3-month safety and efficacy performance goals, according to the results of the Aveir DR i2i investigational device exemption trial.

Medtronic announced it received FDA approval for two of its next-generation miniaturized, leadless pacemakers that are less than one-tenth the size of traditional pacemakers.

Women with prenatal depression were more likely to develop new CVD after delivery compared with those without prenatal depression, according to a study in the Journal of the American Heart Association.

High-powered chargers for electric vehicles are safe for people with implantable cardiac devices, with no evidence of clinically relevant electromagnetic interference, researchers reported.

Children who underwent implantation of a transcatheter leadless pacemaker experienced implant success, good electrical performance and a low level of major complications during short-term follow-up, real-world data show.

Antibiotic irrigation and oral antibiotics on top of chlorhexidine skin preparation, IV antibiotics and antibiotic envelope did not provide additional benefit for high-risk patients after cardiac device implantation, researchers reported.

Assessing moderately accelerated, personalized backup heart rates vs. normal setting of 60 bpm in HFpEF with preexisting pacemaker.

ATLANTA — Compared with conventional physical therapy, physical therapy enhanced with a shoulder pacemaker yielded improved clinical outcomes for patients with functional posterior shoulder instability, according to presented results.